Lurie Cancer Center Member
Elizabeth Eklund, MD
Professor, Medicine, Hematology Oncology Division; Feinberg School of Medicine
View Publications Listing
Dr. Eklund's laboratory focuses on the molecular biology of white blood cell development, with a specific interest in abnormalities that result in myeloid leukemia. Work in the laboratory involves identification of target gene profiles for interferon regulatory transcription factors and Hox homeodomain proteins. Studies focus on understanding how interferon regulatory factors function as myeloid leukemia suppressors, and how Hox proteins function as proto-oncogenes for leukemia. The goals of these studies is to identify molecular targets for therapeutic approaches to myeloid leukemias.
- Discovery May Aid Treatment of Rare Bone Marrow Disorder
- Inhibitor May Help Treat Acute Myeloid Leukemia
- Eklund Named Chair of NIH Study Section